http://www.bcellpartners.com/ Janssen and Pharm
Post# of 30066
Posted On: 08/15/2014 7:46:11 PM
Re: seebisquick #4073
http://www.bcellpartners.com/
Janssen and Pharmacyclics
-> lymphocyte leukemia
not to incite more speculation, but it sparked a little memory for me.
helperwatson • Oct 27, 2013 10:23 AM Flag
8users liked this postsusers disliked this posts1Reply
I am still around. I made a commitment that if I gave bad info, ill timed info, wrong info, I wouldn't post further. I can't be perfect, nothing about this business is quite perfect, regardless of some thinking I will get them all right. I stop posting when things don't come through so my track record stays better. I get info or hear info and things go into limbo for many reasons. I am confident in everything stated, sometimes things get a little delayed. I stand firm that Gerald is switching his approach with BD, I truly believe they are looking to go more things alone and reap the financial benefits. That's a great sign if you're a shareholder, that confidence isn't for a lack of evidence that Gerald and team know great things are around the corner. I truly was aggravated by Riskreturn most of the time, I give him credit for his frank discussion with Gerald and seeing some facts. I would have called Dave nuts before, I now think he's seen some light and you may want to stay in tune with what he's saying some of the time. Regardless of self-fulfilling financial statements, listen to what he said about his Vegas discussion with Gerald. I'll throw one more bone out there and let's see what happens, dark period this week, JDRF is far more interested in MANF that first thought, Novartis still means something, Leukemia may surprise you, yes, MANF is being used in blood cancer treatments right now. There's so many surprises yet to come, much of this you can find by searching MANF's name spelled out with 2013 trial publications and abstracts. Dig hard and you'll be very interested in what you read. Best to all. Less
Janssen and Pharmacyclics
-> lymphocyte leukemia
not to incite more speculation, but it sparked a little memory for me.
helperwatson • Oct 27, 2013 10:23 AM Flag
8users liked this postsusers disliked this posts1Reply
I am still around. I made a commitment that if I gave bad info, ill timed info, wrong info, I wouldn't post further. I can't be perfect, nothing about this business is quite perfect, regardless of some thinking I will get them all right. I stop posting when things don't come through so my track record stays better. I get info or hear info and things go into limbo for many reasons. I am confident in everything stated, sometimes things get a little delayed. I stand firm that Gerald is switching his approach with BD, I truly believe they are looking to go more things alone and reap the financial benefits. That's a great sign if you're a shareholder, that confidence isn't for a lack of evidence that Gerald and team know great things are around the corner. I truly was aggravated by Riskreturn most of the time, I give him credit for his frank discussion with Gerald and seeing some facts. I would have called Dave nuts before, I now think he's seen some light and you may want to stay in tune with what he's saying some of the time. Regardless of self-fulfilling financial statements, listen to what he said about his Vegas discussion with Gerald. I'll throw one more bone out there and let's see what happens, dark period this week, JDRF is far more interested in MANF that first thought, Novartis still means something, Leukemia may surprise you, yes, MANF is being used in blood cancer treatments right now. There's so many surprises yet to come, much of this you can find by searching MANF's name spelled out with 2013 trial publications and abstracts. Dig hard and you'll be very interested in what you read. Best to all. Less
(0)
(0)